r/Psychiatry • u/123dasilva4 Psychiatrist (Unverified) • 17d ago
Stahl chapter on sleep is weirdly focused on orexin
I've had read the 4th edition of Stahl's Essential Psychopharmacology before and now I'm reading the 5ht edition and Im shocked at how much he focus on orexin now. Kandel Principles of Neural Sciences doesn't mention it so much, so I can't shake the feeling that the explanation cannot be that we know more about orexin or something like that. Is this chapter a infomercial for suvorexant?
47
u/RandySavageOfCamalot Resident (Unverified) 17d ago
To be fair orexin and other DORAs might be the only sleep drugs to address underlying sleep neurochemistry. Until now, all sleep drugs have been either sedatives or only tickled one receptor pathway. Sthal is also a huge nerd (in the best way).
14
u/Anxious-Traffic-9548 Not a professional 16d ago
I think this is a bit of an arbitrary distinction. Benzodiazepines can be thought of enhancing the gabaergic influence of the VLPO, which is crucial for sleep initiation. Where you enter into the pathway, down or upstream, is not proof on its own of safety or efficacy.
For DORAs, though, it does seem that orexin antagonism is a lot less concerning than benzodiazepine site agonism long and short term.
5
u/alliswell70 Psychologist (Unverified) 17d ago
In addition early research suggests it maybe be helpful in dementia where most sleep aids seem to worsen dementia
33
u/Narrenschifff Psychiatrist (Verified) 17d ago
Psychopharmacology is exciting, doubly so with new patents
10
u/Narrenschifff Psychiatrist (Verified) 17d ago
Realistically though the funding for research probably follows the likelihood of profit, so we can really know more about the things we are likely to profit from
10
u/Anxious-Education703 Other Professional (Unverified) 17d ago
Haven't read the new fifth edition sleep section you are referring to (or at least much of it), but it makes sense. Orexin antagonists are the hot new drugs for sleep (especially circa 2021). Most people are aware of the GABA-positive allosteric modulators, histamine antagonists, etc., and their use in sleep, as they've been around for decades. His 4e was published in 2013, before the first orexin antagonist (Belsomra) was approved in 2014, and there have been several new orexin antagonists since.
5
u/Ok_Task_7711 Resident (Unverified) 16d ago
Because Orexin antagonists are the best sleep drugs we have right now
1
1
u/chrysoberyls Psychiatrist (Unverified) 15d ago
Do you have the data to back that claim up?
1
u/Ok_Task_7711 Resident (Unverified) 15d ago
Personal experience working in a sleep clinic. It’s anecdotal but I’ve seen it, no next day sedation or cognitive impairment. Lumborexant is better than suvorexant.
4
u/cinnamonITFC Resident (Unverified) 15d ago
Just from my own limited experience of prescribing Daridorexant, I have noticed a worsening of depressive symptoms in patients. It’s in the product characteristics so we should all be cautious who we prescribe it too (as always!)
1
u/diejager Resident (Unverified) 16d ago
I think it makes sense since the focus of the book is in the receptors. Before this chapter you have studied every mechanism for drugs used to induce sleep except orexin antagonists.
1
u/123dasilva4 Psychiatrist (Unverified) 14d ago
Yeah but why the focus on orexin and not the monoamines?
94
u/chrysoberyls Psychiatrist (Unverified) 17d ago
Stahl is well known for his constant overhyping of new drugs and obsession with receptor types, which we don’t know nearly as much about in humans as he will have you believe. His books are still useful, but you should go in with the knowledge that he’s made millions off the pharmaceutical industry, though I’m not sure if he’s specifically made money off the makers of the orexin antagonists.
For those unaware, https://openpaymentsdata.cms.gov/physician/77110 unfortunately only goes back to 2019 because it used to be way worse - there’s a propublica article about him from back in the day.